The global MedTech industry is bouncing back from the Covid-19 pandemic, with Europe playing a leading role in a significant resurgence. MedTechs that were start-ups only a few years ago continue to grow, fuelled by the innovation and entrepreneurialism of their founders and staff.

Yet despite the huge opportunities in data-driven healthcare, it is not enough to have just a great solution. Devices and solutions must integrate with complex health systems and comply with demanding data standards and regulations. Without such data interoperability, uptake by major healthcare providers is unlikely.

To discover more about the data challenges facing MedTechs in the UK and Ireland, we surveyed 100 senior personnel in the industry. The diagnosis is clear: while all companies surveyed say they have interoperability strategies already in place, almost three-quarters (74%) are still struggling to make their data interoperable with today’s healthcare data standards.